3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
4
Phase NA
1
Phase 3
1
Phase 2/3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Multiple Myeloma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia
2
Breast Neoplasms
2
Vomiting
1
Uterine Cervical Neoplasms
1
Trigger Finger Disorder
1
Sarcoma, Alveolar Soft Part
1
Renal Insufficiency
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Pain
1
Neoplasms, Plasma Cell
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nausea
1
Mucositis
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Mast-Cell
1
Leukemia, Hairy Cell
1
Interventions
Ropivacaine
2
Magnesium Sulfate
2
Fentanyl
2
trimebutine 3-thiocarbamoylbenzenesulfonate
1
ramosetron
1
Transdermal Patch
1
Tablets
1
Surveys and Questionnaires
1
Psilocybin
1
Pregabalin
1
Nefopam
1
Morphine
1
Lidocaine
1
Levobupivacaine
1
Ketoprofen
1
Ketamine
1
Injections, Subcutaneous
1
High-Energy Shock Waves
1
Control Groups
1
Capsaicin
1
Bupivacaine
1
Botulinum Toxins, Type A
1
Anesthetics, Local
1
Analgesics, Opioid
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Agnosia
×
Acetaminophen
×
Clear all
NCT02439034
2026-03-16
KETOCOL
Centre Oscar Lambret
Phase 2
Completed
68 enrolled